Risk assessment of khat use in the Netherlands: A review based on adverse health effects, prevalence, criminal involvement and public order

Regulatory Toxicology and Pharmacology

Volumn 52, Issue 3, 2008, Pages 199-207

  Pennings, E J M ^a   Opperhuizen, A ^b   van Amsterdam, J G C ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Cathine; Cathinone; Drug abuse; Illicit drugs; Khat; Public health; Qat; Risk assessment; Toxicity

Indexed keywords

AMPHETAMINE; CATHA EDULIS EXTRACT; CATHINONE; NORPSEUDOEPHEDRINE; PSYCHOTROPIC AGENT;

ADDICTION; AFRICA; ANOREXIA; ARTICLE; CHRONIC TOXICITY; CRIMINAL BEHAVIOR; DIGESTIVE SYSTEM CANCER; GENOTOXICITY; HEALTH HAZARD; HEART ARRHYTHMIA; HUMAN; HYPERTENSION; IMMIGRANT; INSOMNIA; LEGAL ASPECT; MALNUTRITION; MENTAL DISEASE; NETHERLANDS; NONHUMAN; POSTTRAUMATIC STRESS DISORDER; PREVALENCE; PRIORITY JOURNAL; REPRODUCTIVE TOXICITY; RISK ASSESSMENT; SOCIAL ASPECT; SOCIAL STRESS;

CATHA EDULIS;

EID: 56049118663     PISSN: 02732300     EISSN: 10960295     Source Type: Journal    
DOI: 10.1016/j.yrtph.2008.08.005     Document Type: Note

References (110)

1. Abdul-Ghani N., Eriksson M., Kristiansson B., and Qirbi A. The influence of khat-chewing on birth-weight in full-term infants. Soc. Sci. Med. 24 (1987) 625-627
2. ACMD, 2006. Advisory Council on the Misuse of Drugs (ACMD) Published their Report on Khat. Available from: .
3. Adam F., and Hasselot N. Le khat: de l'usage traditionnel au risque toxicomaniaque. [Khat: from traditional usage to risk of drug addiction]. Med. Trop. (Mars.) 54 (1994) 141-144
4. Al Habori M., and Al Mamary M. Long-term feeding effects of Catha edulis leaves on blood constituents in animals. Phytomedicine 11 (2004) 639-644
5. Al Hadrani A.M. Khat induced hemorrhoidal disease in Yemen. Saudi Med. J. 21 (2000) 475-477
6. Al Hebshi N.N., and Skaug N. Effect of khat chewing on 14 selected periodontal bacteria in sub- and supragingival plaque of a young male population. Oral Microbiol. Immunol. 20 (2005) 141-146
7. Al Mamary M., Al Habori M., Al Aghbari A.M., and Baker M.M. Investigation into the toxicological effects of Catha edulis leaves: a short term study in animals. Phytother. Res. 16 (2002) 127-132
8. Al Motarreb A., Al Kebsi M., Al Adhi B., and Broadley K.J. Khat chewing and acute myocardial infarction. Heart 87 (2002) 279-280
9. Al Motarreb A., Baker K., and Broadley K.J. Khat: pharmacological and medical aspects and its social use in Yemen. Phytother. Res. 16 (2002) 403-413
10. Al Motarreb A., Briancon S., Al Jaber N., et al. Khat chewing is a risk factor for acute myocardial infarction: a case-control study. Br. J. Clin. Pharmacol. 59 (2005) 574-581
11. Alem A., Kebede D., and Kullgren G. The prevalence and socio-demographic correlates of khat chewing in Butajira, Ethiopia. Acta Psychiatr. Scand. Suppl. 397 (1999) 84-91
12. Alem A., and Shibre T. Khat induced psychosis and its medico-legal implication: a case report. Ethiop. Med. J. 35 (1997) 137-139
13. Ali A.A., Al Sharabi A.K., Aguirre J.M., and Nahas R. A study of 342 oral keratotic white lesions induced by qat chewing among 2500 Yemeni. J. Oral Pathol. Med. 33 (2004) 368-372
14. Balint G.A., and Balint E.E. On the medico-social aspects of khat (Catha edulis) chewing habit. Hum. Psychopharmacol. 9 (1994) 125-128
15. Balint G.A., Ghebrekidan H., and Balint E.E. Catha edulis, an international socio-medical problem with considerable pharmacological implications. East Afr. Med. J. 68 (1991) 555-561
16. Banjaw M.Y., Miczek K., and Schmidt W. Repeated Catha edulis oral administration enhances the baseline aggressive behavior in isolated rats. J. Neural Transm. 113 (2006) 543-556
17. Belew M., Kebede D., Kassaye M., and Enquoselassie F. The magnitude of khat use and its association with health, nutrition and socio-economic status. Ethiop. Med. J. 38 (2000) 11-26
18. Bhui K., Abdi A., Abdi M., et al. Traumatic events, migration characteristics and psychiatric symptoms among Somali refugees-preliminary communication. Soc. Psychiatry Psychiatr. Epidemiol. 38 (2003) 35-43
19. Brenneisen R., Fisch H.U., Koelbing U., et al. Amphetamine-like effects in humans of the khat alkaloid cathinone. Br. J. Clin. Pharmacol. 30 (1990) 825-828
20. Brenneisen R., and Geisshusler S. Psychotropic drugs. III. Analytical and chemical aspects of Catha edulis Forsk. Pharm. Acta Helv. 60 (1985) 290-301
21. Brenneisen R., Geisshusler S., and Schorno X. Metabolism of cathinone to (-)-norephedrine and (-)-norpseudoephedrine. J. Pharm. Pharmacol. 38 (1986) 298-300
22. Browne D.L. Qat use in New York City. NIDA Res. Monogr. 105 (1990) 464-465
23. Cough S.P., and Cookson I.B. Khat chewing as een cause of psychosis. Lancet i (1984) 455
24. Cox G., and Rampes H. Adverse effects of khat: a review. Adv. Psychiatr. Treat. 9 (2003) 456-463
25. Critchlow S., and Seifert R. Khat-induced paranoid psychosis. Br. J. Psychiatry 150 (1987) 247-249
26. Dhadphale M., Mengech A., and Chege S.W. Miraa (Catha edulis) as a cause of psychosis. East Afr. Med. J. 58 (1981) 130-135
27. Dhadphale M., and Omolo O.E. Psychiatric morbidity among khat chewers. East Afr. Med. J. 65 (1988) 355-359
28. Dimba E.A., Gjertsen B.T., Bredholt T., et al. Khat (Catha edulis)-induced apoptosis is inhibited by antagonists of caspase-1 and -8 in human leukaemia cells. Br. J. Cancer 91 (2004) 1726-1734
29. el Shoura S.M., Abdel-Aziz M., Ali M.E., et al. Deleterious effects of khat addiction on semen parameters and sperm ultrastructure. Hum. Reprod. 10 (1995) 2295-2300
30. Geisshusler S., and Brenneisen R. The content of psychoactive phenylpropyl and phenylpentenyl khatamines in Catha edulis Forsk. of different origin. J. Ethnopharmacol. 19 (1987) 269-277
31. Giannini A.J., Burge H., Shaheen J.M., and Price W.A. Khat: another drug of abuse?. J. Psychoactive Drugs 18 (1986) 155-158
32. Giannini A.J., and Castellani S. A manic-like psychosis due to khat (Catha edulis Forsk.). J. Toxicol. Clin. Toxicol. 19 (1982) 455-459
33. Giannini A.J., Miller N.S., and Turner C.E. Treatment of khat addiction. J. Subst. Abuse Treat. 9 (1992) 379-382
34. Goldenberg D., Lee J., Koch W.M., et al. Habitual risk factors for head and neck cancer. Otolaryngol. Head Neck Surg. 131 (2004) 986-993
35. Goudie A.J. Comparative effects of cathinone and amphetamine on fixed-interval operant responding: a rate-dependency analysis. Pharmacol. Biochem. Behav. 23 (1985) 355-365
36. Granek M., Shalev A., and Weingarten A.M. Khat-induced hypnagogic hallucinations. Acta Psychiatr. Scand. 78 (1988) 458-461
37. Griffiths P. Qat Use in London: A Study of Qat Use Among een Sample of Somalis Living in London (1998), Crown Publishers
38. Griffiths P., Gossop M., Wickenden S., et al. A transcultural pattern of drug use: qat (khat) in the UK. Br. J. Psychiatry 170 (1997) 281-284
39. Hakim L.Y. Influence of khat on seminal fluid among presumed infertile couples. East Afr. Med. J. 79 (2002) 22-28
40. Halbach H. Medical aspects of the chewing of khat leaves. Bull. World Health Organ. 47 (1972) 21-29
41. Halbach H. Khat-the problem today. NIDA Res. Monogr. 27 (1979) 318-319
42. Halket J.M., Karasu Z., and Murray-Lyon I.M. Plasma cathinone levels following chewing khat leaves (Catha edulis Forsk.). J. Ethnopharmacol. 49 (1995) 111-113
43. Hassan N.A., Gunaid A.A., Abdo-Rabbo A.A., et al. The effect of Qat chewing on blood pressure and heart rate in healthy volunteers. Trop. Doct. 30 (2000) 107-108
44. Hassan N.A., Gunaid A.A., El Khally F.M., and Murray-Lyon I.M. The effect of chewing khat leaves on human mood. Saudi Med. J. 23 (2002) 850-853
45. Hassan N.A., Gunaid A.A., Khally F.M., et al. Khat chewing and arterial blood pressure. een randomized controlled clinical trial of alpha-1 and selective beta-1 adrenoceptor blockade. Saudi Med. J 26 (2005) 537-541
46. Hassan N.A., Gunaid A.A., Khally F.M., and Murray-Lyon I.M. The subjective effects of chewing qat leaves in human volunteers. Ann. Saudi Med. 22 (2002) 34-37
47. Hill C.M., and Gibson A. The oral and dental effects of q'at chewing. Oral Surg. Oral Med. Oral Pathol. 63 (1987) 433-436
48. Ihunwo A.O., Kayanja F.I., and Amadi-Ihunwo U.B. Use and perception of the psychostimulant, khat (Catha edulis) among three occupational groups in south western Uganda. East Afr. Med. J. 81 (2004) 468-473
49. ISDD, 1994. Druglink Factsheet No. 9. Khat (Qat, Chat). Institute for the Study of Drug Dependence, London.
50. Islam M.W., al Shabanah O.A., al Harbi M.M., and al Gharably N.M. Evaluation of teratogenic potential of khat (Catha edulis Forsk.) in rats. Drug Chem. Toxicol. 17 (1994) 51-68
51. Jager A.D., and Sireling L. Natural history of khat psychosis. Aust. NZ J. Psychiatry 28 (1994) 331-332
52. Jorgensen E., and Kaimenyi J.T. The status of periodontal health and oral hygiene of Miraa (Catha edulis) chewers. East Afr. Med. J. 67 (1990) 585-590
53. Kalix P. Hyperthermic response to (-)-cathinone, an alkaloid of Catha edulis (khat). J. Pharm. Pharmacol. 32 (1980) 662-663
54. Kalix P. Effect of the alkaloid (-)-cathinone on the release of radioactivity from rat striatal tissue prelabelled with 3H-serotonin. Neuropsychobiology 12 (1984) 127-129
55. Kalix P. Khat: scientific knowledge and policy issues. Br. J. Addict. 82 (1987) 47-53
56. Kalix P. Khat: a plant with amphetamine effects. J. Subst. Abuse Treat. 5 (1988) 163-169
57. Kalix P. Pharmacological properties of the stimulant khat. Pharmacol. Ther. 48 (1990) 397-416
58. Kalix P. Cathinone, a natural amphetamine. Pharmacol. Toxicol. 70 (1992) 77-86
59. Kalix P. Khat, an amphetamine-like stimulant. J. Psychoactive Drugs 26 (1994) 69-74
60. Kalix P., and Braenden O. Pharmacological aspects of the chewing of khat leaves. Pharmacol. Rev. 37 (1985) 149-164
61. Kalix P., Geisshusler S., and Brenneisen R. Differential effect of phenylpropyl- and phenylpentenyl-khatamines on the release of radioactivity from rabbit atria prelabelled with 3H-noradrenaline. Pharm. Acta Helv. 62 (1987) 332-334
62. Kalix P., Geisshusler S., and Brenneisen R. The effect of phenylpentenyl-khatamines on the release of radioactivity from rat striatal tissue prelabelled with [3H]dopamine. J. Pharm. Pharmacol. 39 (1987) 135-137
63. Kalix P., and Khan I. Khat: an amphetamine-like plant material. Bull. World Health Organ. 62 (1984) 681-686
64. Kassie F., Darroudi F., Kundi M., et al. Khat (Catha edulis) consumption causes genotoxic effects in humans. Int. J. Cancer 92 (2001) 329-332
65. Kennedy J.G., Teague J., Rokaw W., and Cooney E. A medical evaluation of the use of qat in North Yemen. Soc. Sci. Med. 17 (1983) 783-793
66. Khattab N.Y., and Amer G. Undetected neuropsychophysiological sequelae of khat chewing in standard aviation medical examination. Aviat. Space Environ. Med. 66 (1995) 739-744
67. Kite G.C., Ismail M., Simmonds M.S., and Houghton P.J. Use of doubly protonated molecules in the analysis of cathedulins in crude extracts of khat (Catha edulis) by liquid chromatography/serial mass spectrometry. Rapid Commun. Mass Spectrom. 17 (2003) 1553-1564
68. Kuczkowski K.M. Re: cathinone: a new differential in the diagnosis of pregnancy induced hypertension. East Afr. Med. J. 81 (2004) 436
69. Kuczkowski K.M. Herbal ecstasy: cardiovascular complications of khat chewing in pregnancy. Acta Anaesthesiol. Belg. 56 (2005) 19-21
70. Kummoona R. Surgical reconstruction of the temporomandibular joint for chronic subluxation and dislocation. Int. J. Oral Maxillofac. Surg. 30 (2001) 344-348
71. Litman A., Levav I., Saltz-Rennert H., and Maoz B. The use of khat. An epidemiological study in two Yemenite villages in Israel. Cult. Med. Psychiatry 10 (1986) 389-396
72. Luqman W., and Danowski T.S. The use of khat (Catha edulis) in Yemen. Social and medical observations. Ann. Intern. Med. 85 (1976) 246-249
73. Macigo F.G., Mwaniki D.L., and Guthua S.W. The association between oral leukoplakia and use of tobacco, alcohol and khat based on relative risks assessment in Kenya. Eur. J. Oral Sci. 103 (1995) 268-273
74. Makki, I., 1975. Oral Carcinomas and their Relationship to Khat and Shamma Abuses. Thesis University of Heidelberg (GDR).
75. Marker P., and Krogdahl A. Plasma cell gingivitis apparently related to the use of khat: report of a case. Br. Dent. J. 192 (2002) 311-313
76. McLaren P. Khat psychosis. Br. J. Psychiatry 150 (1987) 712-713
77. Mengel R., Eigenbrodt M., Schunemann T., and Flores-de-Jacoby L. Periodontal status of a subject sample of Yemen. J. Clin. Periodontol. 23 (1996) 437-443
78. Meteki D., and Hughes B.M. A brief survey of khat use among juvenile delinquents in Addis Ababa, Ethiopia. Irish J. Psychol. 22 (2001) 51-58
79. Mujlli H.M., Bo X., and Zhang L. The effect of Khat (Catha edulis) on acute cerebral infarction. Neuroscience 10 (2005) 219-222
80. Mwenda J.M., Arimi M.M., Kyama M.C., and Langat D.K. Effects of khat (Catha edulis) consumption on reproductive functions: a review. East Afr. Med. J. 80 (2003) 318-323
81. Nabozoka D., and Badhadhe F.A. Use and perceptions of khat among young Somalis in een UK city. Addict. Res. 8 (2000) 5-26
82. Nasher A.A., Qirbi A.A., Ghafoor M.A., et al. Khat chewing and bladder neck dysfunction. A randomized controlled trial of alpha 1-adrenergic blockade. Br. J. Urol. 75 (1995) 597-598
83. Nasr A.H., and Khatri M.L. Head and neck squamous cell carcinoma in Hajjah, Yemen. Saudi Med. J. 21 (2000) 565-568
84. Nencini P., and Ahmed A.M. Khat consumption: a pharmacological review. Drug Alcohol Depend. 23 (1989) 19-29
85. Nencini P., Ahmed A.M., and Elmi A.S. Subjective effects of khat chewing in humans. Drug Alcohol Depend. 18 (1986) 97-105
86. Nielen R.J., van der Heijden F.M., Tuinier S., and Verhoeven W.M. Khat and mushrooms associated with psychosis. World J. Biol. Psychiatry 5 (2004) 49-53
87. NND, 2007. Internal Report of the Dutch National Network Drug Expertise (NND) prepared for CAM (not published).
88. Numan N. Exploration of adverse psychological symptoms in Yemeni khat users by the Symptoms Checklist-90 (SCL-90). Addiction 99 (2004) 61-65
89. Odenwald M., Neuner F., Schauer M., et al. Khat use as risk factor for psychotic disorders: a cross-sectional and case-control study in Somalia. BMC Med. 3 (2005) 5
90. Odenwald M. Chronic khat use and psychotic disorders: a review of the literature and future aspects. Sucht 53 (2007) 9-22
91. Othieno C.J., Kathuku D.M., and Ndetei D.M. Substance abuse in outpatients attending rural and urban health centres in Kenya. East Afr. Med. J. 77 (2000) 592-595
92. Pantelis C., Hindler C.G., and Taylor J.C. Khat, toxic reactions to this substance, its similarities to amphetamine, and the implications of treatment for such patients. J. Subst. Abuse Treat. 6 (1989) 205-206
93. Pantelis C., Hindler C.G., and Taylor J.C. Use and abuse of khat (Catha edulis): a review of the distribution, pharmacology, side effects and a description of psychosis attributed to khat chewing. Psychol. Med. 19 (1989) 657-668
94. Patel N.B. Mechanism of action of cathinone: the active ingredient of khat (Catha edulis). East Afr. Med. J. 77 (2000) 329-332
95. Pennings, E.J.M., 2006. Assessment of Khat (Catha edulis Forsk.). WHO 4.4 Khat Critical Review. 34th ECDD. WHO Technical Report Series, No. 942.
96. Qureshi S., Tariq M., Parmar N.S., and al Meshal I.A. Cytological effects of khat (Catha edulis) in somatic and male germ cells of mice. Drug Chem. Toxicol. 11 (1988) 151-165
97. Selassie S.G., and Gebre A. Rapid assessment of drug abuse in Ethiopia. Bull. Narc. 48 (1996) 53-63
98. Soufi H.E., Kameswaran M., and Malatani T. Khat and oral cancer. J. Laryngol. Otol. 105 (1991) 643-645
99. Stefan J., and Mathew B. Khat chewing: an emerging drug concern in Australia?. Aust. NZ J. Psychiatry 39 (2005) 842-843
100. Tariq M., Al Meshal I., and Al Saleh A. Toxicity studies on Catha edulis. Dev. Toxicol. Environ. Sci. 11 (1983) 337-340
101. Tariq M., Qureshi S., Ageel A.M., and al Meshal I.A. The induction of dominant lethal mutations upon chronic administration of khat (Catha edulis) in albino mice. Toxicol. Lett. 50 (1990) 349-353
102. Toennes S.W., Harder S., Schramm M., et al. Pharmacokinetics of cathinone, cathine and norephedrine after the chewing of khat leaves. Br. J. Clin. Pharmacol. 56 (2003) 125-130
103. Toennes S.W., and Kauert G.F. Driving under the influence of khat-alkaloid concentrations and observations in forensic cases. Forensic Sci. Int. 140 (2004) 85-90
104. Van Amsterdam J.G.C., Best W., Opperhuizen A., et al. Evaluation of a procedure to assess the adverse effects of illicit drugs. Regul. Toxicol. Pharmacol. 39 (2004) 1-4
105. Warfa N., Klein A., Bhui K., et al. Khat use and mental illness: a critical review. Soc. Sci. Med. 65 (2007) 309-318
106. WHO, 1980. Review of the pharmacology of khat. Report of a WHO advisory group. UN Bull. Narc. 32, 83-93.
107. WHO, 2003. WHO Expert Committee on Drug Dependence. Thirty-third report. Geneva, World Health Organization, 1993 (WHO Technical Report Series, No. 915), 25 p.
108. Widler P., Mathys K., Brenneisen R., et al. Pharmacodynamics and pharmacokinetics of khat: a controlled study. Clin. Pharmacol. Ther. 55 (1994) 556-562
109. Yousef G., Huq Z., and Lambert T. Khat chewing as a cause of psychosis. Br. J. Hosp. Med. 54 (1995) 322-326
110. Zelger J.L., Schorno H.X., and Carlini E.A. Behavioural effects of cathinone, an amine obtained from Catha edulis Forsk.: comparisons with amphetamine, norpseudoephedrine, apomorphine and nomifensine. Bull. Narc. 32 (1980) 67-81